MSU research sheds new light on dangers of high cholesterolAugust 30, 2005EAST LANSING, Mich. - Research by a Michigan State University cardiologist published in the September edition of Clinical Cardiology has shed new light on the role that cholesterol plays in causing heart attacks, strokes and other cardiovascular events in humans. The work of George Abela, a professor in MSU's Department of Medicine and chief of the department's cardiology section, finds that cholesterol that has built up along the wall of an artery and crystallized from a liquid to a solid state can expand and then burst, sending material into the bloodstream. It is this chain of events - the expansion of the liquid cholesterol as it crystallizes into a solid - that kick-starts the body's natural clotting process which, unfortunately in this case, works against the body, essentially shutting down the artery. "As the cholesterol crystallizes, two things can happen," Abela said. "If it's a big pool of cholesterol, it will expand and just tear the cap off the deposit in the arterial wall. Or the crystals, which are sharp, needle-like structures, poke their way through the membrane covering the cholesterol deposit, like nails through wood." It is the presence of the cholesterol crystals and other debris material released by the plaque rupture into the bloodstream that activates the clotting mechanism. "What the clotting system is doing is reacting to an injury in the artery," he said. "Once a rupture or erosion of the surface of the artery occurs, then the clotting system is activated to do its job." Abela compared the crystallization of the cholesterol to putting a plastic bottle of water into a freezer. Over time the water freezes and expands, pushing its way out of the bottle or breaking the bottle altogether. What this work also means is that physicians and other health care providers now have another weapon in their arsenal against cardiovascular disease. "So far, treatments have not been focused on this process," Abela said. "Now we have a target to attack with the various approaches we have. In the past, we've treated the various stages that lead to this final stage, rather than preventing or treating this final stage of the condition." Abela stressed that it remains imperative that people use diet and exercise to keep cholesterol levels low. "This really drives the point home how important cholesterol control can be," he said. Until now, scientists had thought that inflammation of the wall had caused the breakdown of the cap that kept the cholesterol in the arterial plaque from rupturing. Abela said his findings don't necessarily discount the inflammation theory, but rather add another dimension to it. "As the crystals form, they dig their way through the wall of the artery, and that may be a trigger for the inflammation," he said. "Inflammation is a normal mechanism, one that kicks in to repair the damage. That is why it is common to see inflammation at the site of these events." The research was conducted in Abela's lab, research that he said was "as simple as science can get." Essentially, Abela and colleagues took varying amounts of cholesterol, reduced it to a liquid form, and then watched it expand as it solidified. In doing so, it tore through thin biological membranes. "After the cholesterol crystallized, its volume was about 45 percent larger than what we started with," he said. "And the entire process took all of about three minutes." Michigan State University |
|||||||||||||||||||||
| Related Cholesterol Current Events and Cholesterol News Articles Study suggests dentists can identify patients at risk for fatal cardiovascular event A new study indicates dentists can play a potentially life-saving role in health care by identifying patients at risk of fatal heart attacks and referring them to physicians for further evaluation. UCLA researchers reconstitute enzyme that synthesizes cholesterol drug lovastatin Researchers from the UCLA Henry Samueli School of Engineering and Applied Science have for the first time successfully reconstituted in the laboratory the enzyme responsible for producing the blockbuster cholesterol-lowering drug lovastatin. Researchers identify the three killer indicators that are even worse than high cholesterol Researchers at the University of Warwick have identified a particular combination of health problems that can double the risk of heart attack and cause a three-fold increase in the risk of mortality. Can charcoal fight heart disease in kidney patients? Charcoal may provide a new approach to managing the high rate of heart disease in patients with advanced kidney disease, according to preliminary research being presented at the American Society of Nephrology's 42nd Annual Meeting and Scientific Exposition in San Diego, CA. Widely used cholesterol-lowering drug may prevent progression Simvastatin, a commonly used, cholesterol-lowering drug, may prevent Parkinson's disease from progressing further. Neurological researchers at Rush University Medical Center conducted a study examining the use of the FDA-approved medication in mice with Parkinson's disease and found that the drug successfully reverses the biochemical, cellular and anatomical changes caused by the disease. Statins show dramatic drug and cell dependent effects in the brain Besides their tremendous value in treating high cholesterol and lowering the risk of heart disease, statins have also been reported to potentially lower the risks of other diseases, such as dementia. Web-based nutrition program reduces health care costs for employees with cardiac risk factors Researchers from Boston University School of Medicine (BUSM) and Boston University School of Public Health (BUSPH) have shown that an employer-sponsored, internet-based diet and exercise program shows promise as a low-cost benefit to lower healthcare costs for those at higher risk for above-average costs and healthcare utilization such as cardiac, hyperlipidemia, hypertension or diabetes patients. These findings appear in the current issue of the Journal of Medical Internet Research. Cholesterol-lowering medicines may be effective against cancer Statins lower cholesterol by blocking certain enzymes involved in our metabolism. Experts unveil new CVD guidelines and position papers Several new guidelines and position papers offering the most up to date information to ensure that clinicians practice evidence-based medicine were released at the Canadian Cardiovascular Congress 2009 this week. Adding ezetimibe to atorvastatin improves lipid control Adding ezetimibe to atorvastatin significantly boosted the attainment of lipid targets as specified by both Canadian and European guidelines in elderly patients aged 65 and older and the combination produced superior results than simply increasing the dose of atorvastatin alone. More Cholesterol Current Events and Cholesterol News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||